RxDoctor Payments Data

Erin McCluskey, PA

Physician Assistant · Loysville, PANPI 1679764088

Payments from drug & device makers

$6,088in general payments, 2019–2025

Across 365 payments — averaging $16.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$1K
  • AbbVie$744
  • GSK$630
  • Boehringer Ingelheim$419
  • AstraZeneca$397
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$290
  • plus $3K from 38 others

What the payments were for

  • Food & beverage$6,070100%
  • Education$180%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$6,088 in reported general payments places this provider in the 95th percentile of 6,643 physician assistant providers in Pennsylvania.

See all physician assistant providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$44,783
Medicare patients
117
Services billed
691

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin89$74,571
OzempicSemaglutide56$63,458
MounjaroTirzepatide28$37,507
RybelsusSemaglutide33$33,845
EliquisApixaban33$31,458
KerendiaFinerenone33$22,848
JanuviaSitagliptin Phosphate26$21,285
RexultiBrexpiprazole11$15,100
MyrbetriqMirabegron17$11,953
Spiriva RespimatTiotropium Bromide17$8,412
TradjentaLinagliptin13$6,607
Rosuvastatin Calcium258$4,251
Montelukast Sodium270$3,182
Atorvastatin Calcium273$2,287
Metoprolol Succinate118$1,738

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$1,096$97,30389 claims
Boehringer IngelheimJardiance, Spiriva Respimat, Tradjenta$419$89,590119 claims
Lilly USA, LLCMounjaro$255$37,50728 claims
PfizerEliquis$193$31,45833 claims
BayerKerendia$142$22,84833 claims
MerckJanuvia$126$21,28526 claims
Otsuka America Pharmaceutical, Inc.Rexulti$76$15,10011 claims
Astellas Pharma US IncMyrbetriq$35$11,95317 claims
AbbVieSynthroid$744$1,34034 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 6,643 physician assistant providers in Pennsylvania.

Other physician assistant in Loysville

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →